Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers

Clinical trial NCT04679493 · COMPLETED

Trial details

NCT number: NCT04679493
Sponsor: NP Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Covid19 Healthy Volunteers

Start date: 2020-12-17
Primary completion: 2021-04-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.